$NBIS

Boynton John Wilson IV sold $1.4M of NBIS

Boynton John Wilson IV sold 6,958 shares of Nebius Group N.V. (NBIS) at an average of $197.00 ($187.79–$202.29, $1.37M total) across 11 trades on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Boynton John Wilson IV
Published Jul 17, 2026, 4:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 17, 2026, 4:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Neutral
medium confidence
Mentioned
$NBIS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISNeutralLow
01

Why it matters

The disclosed sale reduces the director’s direct holdings from the pre-transaction level to 421,140 shares, but it does not include any new guidance, deal, or regulatory development.

02

Market read

Traders may monitor insider activity as a sentiment input, but the 10b5-1 framing typically lowers the signal strength.

03

What to watch

The article does not disclose whether other insiders or the company itself made offsetting purchases, nor does it provide context on total insider ownership changes beyond the post-transaction share count.

Relevance 5/10Novelty 5/10Timing: after-hours/next-session read-through following the July 17 Form 4 filing

Background

The article is a primary-source SEC Form 4 insider transaction for Nebius Group N.V. (NBIS).

Company-level read

Ticker impact

$NBISNeutralMedium confidence
Context

Nebius Group N.V. director Boynton John Wilson IV sold $1.37M of NBIS shares via an open-market sale under a 10b5-1 plan on July 15.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing is a Form 4 insider transaction (open-market sale) with a pre-arranged 10b5-1 plan, and the article provides no new company fundamentals beyond the sale details.

Market effects

No clear sector read-through; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Nebius Group N.V.

    Subject of the Form 4 insider sale disclosure.

  • Boynton John Wilson IV

    Director who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.